CAV1 and prostate cancer: CAV1 has been repeatedly linked to cancer progression, either as a tumor suppressor, as its absence is associated with a poor prognosis [29] (e.g., aggressive prostate cancer [30, 31], breast cancer [32], and gastric cancer [33]), or as a tumor and metastasis promoter [34–38].